{"schema_version":"1","generated_at":"2026-11-21T22:11:27.490Z","data_as_of":null,"url":"https://www.findmykol.com/kol/cassandra-calabrese","json_url":"https://www.findmykol.com/kol/cassandra-calabrese/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"cassandra-calabrese","name":"Cassandra Calabrese","credential":"DO","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Cassandra Calabrese is a Rheumatology/Immunology physician affiliated with Cleveland Clinic. OpenAlex indexes 112 publications with 3,712 citations (h-index 29).","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":112,"cited_by_count":3712,"h_index":29,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":18,"shown":3,"withheld":15,"rows":[{"payer":"GENZYME CORPORATION","program_year":2025,"amount_usd":9128.37,"payment_count":5},{"payer":"Invivyd Inc","program_year":2025,"amount_usd":3737.5,"payment_count":3},{"payer":"Amgen Inc.","program_year":2025,"amount_usd":321.19,"payment_count":3}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":6,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":41.4,"classes_total":7,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":13.6,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":23},{"class":"TNF inhibitor","setting":"prescribed","share_pct":9.2,"drugs":[{"name":"Humira(Cf) Pen","share_pct":46.9},{"name":"Enbrel Sureclick","share_pct":37},{"name":"Humira Pen","share_pct":16}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":30.7,"classes_total":3,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":27.4,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":58},{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":1.9,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Antiparasitic","share_pct":18.1,"classes_total":1,"classes":[{"class":"Antimalarial","setting":"prescribed","share_pct":18.1,"drugs":[{"name":"Hydroxychloroquine Sulfate","share_pct":100}],"max_beneficiaries":34}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"A scoping review of vasculitis as an immune-related adverse event from checkpoint inhibitor therapy of cancer: Unraveling the complexities at the intersection of immunology and vascular pathology","year":2024,"journal":"Seminars in Arthritis and Rheumatism","source_url":"https://doi.org/10.1016/j.semarthrit.2024.152440","status":"verified"},{"title":"Long-Term Cardiovascular Outcomes of Immune Checkpoint Inhibitor-Related Myocarditis: A Large Single-Centre Analysis","year":2024,"journal":"ESC Heart Failure","source_url":"https://doi.org/10.1002/ehf2.15131","status":"verified"},{"title":"Mechanistic insights into bone remodelling dysregulation by human viral pathogens","year":2024,"journal":"Nature Microbiology","source_url":"https://doi.org/10.1038/s41564-023-01586-6","status":"verified"},{"title":"2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases","year":2023,"journal":"Arthritis Care & Research","source_url":"https://doi.org/10.1002/acr.25045","status":"verified"},{"title":"Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis","year":2023,"journal":"Annals of the Rheumatic Diseases","source_url":"https://doi.org/10.1136/ard-2023-223885","status":"verified"}],"source":"works"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":15,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}